A 13G filed today reports that Lord Abbett increased their ownership of ACO from 7.3% to 10.3% during August. Responding to those who have recently wondered on this board, I am not (and have never been) an employee of AMCOL. I have been a shareholder since @ 1994-5 and have received substantial (for me) wealth creation from the experience.
Suppose activist funds got involved. What might they do? Possibly sell litter operation, as conceivably it could support a relatively high debt as a consumer staple, but that wouldn't do much for ACO. They already considered spinning off nanotech once. For fun, anyone else have any ideas?
I feel their personal care / cosmetic delivery system platform - Polypore product line does not fit well with the clay based colorant / rheology line. It does not appear to be a core competency. I would recommend selling the line to someone more entrenched into PC industry. This however would not be significant money generator.